5 hours Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue EstimatesZacks
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of -17.24% and 20.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X